XORTX Therapeutics Inc.

Biotech  XORTX Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.  

Learn more at
http://www.xortx.com
adavidoff@xortx.com
1 403 607-2621

The Richmond Review

First page of slide deck

Fri Feb 14th, 2020

  • SEC Filings3:00 AM

    [Amend] Statement of acquisition of beneficial ownership by individuals – Form SC 13G/A

  • SEC Filings3:00 AM

    [Amend] Statement of acquisition of beneficial ownership by individuals – Form SC 13G/A